Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... Read More

Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... Read More

Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More

Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More

Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More

Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 23 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More

WNBA Results September 22, 2026: A'ja Wilson, Caitlin Clark Star as Aces, Fever Win; Valkyries Lose in Overtime

India, Sept. 23 -- Another busy night in the WNBA has added fresh twists to the playoff picture, with several teams making their latest moves as the regular season enters its final stretch. The Golden... Read More

Mahindra Thar OG vs Maruti Suzuki Jimny: Monthly EMI comparison

India, Sept. 23 -- Mahindra has launched the Thar OG, the new iteration of the mighty ladder-frame SUV, which continues to woo a large number of car buyers and off-roading enthusiasts in India. The ne... Read More

'Invisible hand': Opposition questions ECI after report on commissioners' SIR concerns

India, Sept. 23 -- Opposition leaders on Wednesday questioned the Election Commission of India (ECI)'s functioning after an Indian Express (IE) investigation showed that two of the three election comm... Read More

Ankush Panghal vs Hamsa Vogel Boxing Live Streaming, Asian Games 2026: Men's 80kg Preliminaries Bout Start Time, Where To Watch

India, Sept. 23 -- Ankush Panghal begins his Asian Games 2026 boxing campaign on Wednesday as the Indian boxer takes on Hamsa Vogel of Bahrain in the men's 80kg round of 16 at the Nishio Gymnasium in ... Read More

• ««
• «
• 4615
• 4616
• 4617
• 4618
• 4619
• 4620
• 4621
• 4622
• 4623
• 4624
• »
• »»